- Home
- FULC vs NATH Comparison
FULC vs NATH Comparison
Compare FULC & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- NATH
- Stock Information
- Founded
- FULC 2015
- NATH 1916
- Country
- FULC United States
- NATH United States
- Employees
- FULC N/A
- NATH N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- NATH Restaurants
- Sector
- FULC Health Care
- NATH Consumer Discretionary
- Exchange
- FULC Nasdaq
- NATH Nasdaq
- Market Cap
- FULC 469.0M
- NATH 442.2M
- IPO Year
- FULC 2019
- NATH N/A
- Fundamental
- Price
- FULC $7.87
- NATH $110.34
- Analyst Decision
- FULC Buy
- NATH
- Analyst Count
- FULC 7
- NATH 0
- Target Price
- FULC $10.43
- NATH N/A
- AVG Volume (30 Days)
- FULC 618.0K
- NATH 36.6K
- Earning Date
- FULC 10-29-2025
- NATH 11-07-2025
- Dividend Yield
- FULC N/A
- NATH 1.81%
- EPS Growth
- FULC N/A
- NATH 9.62
- EPS
- FULC N/A
- NATH 5.77
- Revenue
- FULC N/A
- NATH $150,413,000.00
- Revenue This Year
- FULC N/A
- NATH N/A
- Revenue Next Year
- FULC N/A
- NATH N/A
- P/E Ratio
- FULC N/A
- NATH $18.55
- Revenue Growth
- FULC 2752.05
- NATH 6.38
- 52 Week Low
- FULC $2.32
- NATH $75.15
- 52 Week High
- FULC $10.11
- NATH $118.50
- Technical
- Relative Strength Index (RSI)
- FULC 40.58
- NATH 56.55
- Support Level
- FULC $8.42
- NATH $103.44
- Resistance Level
- FULC $9.47
- NATH $108.49
- Average True Range (ATR)
- FULC 0.80
- NATH 2.22
- MACD
- FULC -0.21
- NATH 0.02
- Stochastic Oscillator
- FULC 7.11
- NATH 87.23
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.